Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

Healthcare Technology Drug Manufacturers - Specialty & Generic Software - Application Cannabis
GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

GB Group Ord Shs > Doing the math
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by silkroad007on Jan 25, 2018 10:35pm
102 Views
Post# 27437707

RE:RE:RE:RE:RE:RE:RE:RE:Doing the math

RE:RE:RE:RE:RE:RE:RE:RE:Doing the mathBingo! But are you really surprised it traded down, look st all the uneducated drivel on this board. If weed stocks did one thing it was bringing out retail that has no clue .  Takes 3 seconds to digest the offfer and realize your way better off flipping to VMED.  The gap will correct in due time.  The volume is really low on this stock so not to many bright bulbs can affect the price


quote=NGlong]Ok so ACB said they will pay 1.1 billion for CMED so if CMED has 24.433341 million outstanding shares that would give you a CMED share price of 45.02? What I get from this merger was ACB will offer the 3.4 ratio to 1 ACB share at a $12.65 so if ACB should go lower than $12.65 ACB would cover or front the first $140 million below $12.65 after that its fair game, so I am realy puzzled as to why CMED's SP has fallen, they are just about gurrantted an ACB share at $12.65 and we are not even there yet?[/quote]

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities